Tetraoxanes: Synthetic and medicinal chemistry perspective

Medicinal Research Reviews

Volumn 32, Issue 3, 2012, Pages 581-610

  Kumar, Nitin ^a   Singh, Ram ^a   Rawat, Diwan S ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Antimalarials; Artemisinine; Endoperoxides; Plasmodium; Tetraoxane

Indexed keywords

1,10 DIMETHYL 7,8,15,16 TETRAOXADISPIRO[5.2.5.2]HEXADECANE; AMINE; AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; ANTIMYCOBACTERIAL AGENT; ANTINEOPLASTIC AGENT; ARTEMISININ; BENZALDEHYDE; CYCLOALKANONE; STEROID; TETRAOXANE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; IC 50; MAXIMUM TOLERATED DOSE; MELANOMA; MYCOBACTERIUM TUBERCULOSIS; MYELOID LEUKEMIA; NEUROTOXICITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PLASMODIUM FALCIPARUM; SINGLE DRUG DOSE; STRUCTURE ACTIVITY RELATION; UTERINE CERVIX CARCINOMA; X RAY CRYSTALLOGRAPHY;

ANTIMALARIALS; ANTITUBERCULAR AGENTS; DRUG RESISTANCE; HUMANS; MALARIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAOXANES;

EID: 80052203583     PISSN: 01986325     EISSN: 10981128     Source Type: Journal    
DOI: 10.1002/med.20223     Document Type: Article

References (90)

1. Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002;415:680-685.
2. Haynes RK, Vonwiller SC. From Qinghao, marvelous herb of antiquity, to the antimalarial trioxane Qinghaosu. Some remarkable new chemistry. Acc Chem Res 1997;30:73-79.
3. Robert A, Dechy-Cabaret O, Cazelles J, Meunier B. From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. Acc Chem Res 2002;35:167-174.
4. Wu YK. How might quinghaosu (artemisinin) and related compounds kill the intraerythrocytic malaria parasite? A chemist's view. Acc Chem Res 2002;35:255-259.
5. Dong Y. Synthesis and antimalarial activity of 1, 2, 4, 5-tetraoxanes. Mini Rev Med Chem 2002;2:113-123.
6. Tang Y, Dong Y, Vennerstrom JL. Synthetic peroxides as antimalarials. Med Res Rev 2004;24:425-448.
7. Wiesner J, Ortmann R, Jomaa H, Schlitzer M. New antimalarial drugs. Angew Chem Int Ed Engl 2003;42:5274-5293.
8. Padmanaban G, Nagaraj VA, Rangarajan PN. Drugs and drug targets against malaria. Curr Sci 2007;92:1545-1555.
9. Ridley RG. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 2002;415:686-693.
10. Knell AJ. Malaria. Oxford: Oxford University Press; 1991.
11. Klayman DL. Quinghaosu (artimisinin): An antimalarial drug from China. Science 1985;228:1049-1055.
12. Butler AR, Wu YL. Artemisinin (Qinghaosu): A new type of antimalarial. Drug Chem Soc Rev 1992;21:85-90.
13. Klayman DL. Artemisia annua: From weed to respectable antimalarial plant. ACS Sump Ser 1993;534:242-255.
14. O'Neill PM, Posner GH. A medicinal chemistry perspective on artemisinin and related endoperoxides. J Med Chem 2004;47:2945-2964.
15. Haynes RK. From artemisinin to new artemisinin antimalarials: Biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements. Curr Top Med Chem 2006;6:509-537.
16. Vroman JA, Alvina-Gaston M, Avery MA. Current progress in the chemistry, Medicinal chemistry and drug design of artemisinin based antimalarials. Curr Pharm Des 1999;5:101-138.
17. Posner GH, O'Neill PM. Knowledge of the proposed chemical mechanism of action and cytochrome P450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides. Acc Chem Res 2004;37:397-404.
18. Jefford CW. New developments in synthetic peroxidic drugs as artemisinin mimics. Drug Dis Today 2007;12:487-495.
19. Vennerstrom JL, Fu H-N, Ellis WY, Ager AL, Jr, Wood JK, Andersen SL, Gerena L, Milhous WK. Dispiro-1, 2, 4, 5-tetraoxanes: A new class of antimalarial peroxides. J Med Chem 1992;35:3023-3027.
20. Fichter F, Lurie S. The ketone peroxide of ethyl levulinate. Helv Chem Acta 1931;14:1445-1448.
21. Masuyama A, Wu J-M, Nojima M, Kim H-S, Wataya Y. 1, 2, 4, 5-Tetraoxacycloalkanes: Synthesis and antimalarial activity. Mini Rev Med Chem 2005;5:1035-1043.
22. Story PR, Busch P. Advances in organic chemistry, vol. 8. In: Taylor EC, editor. New York: Wiley; 1972. pp 67-95.
23. Harding MJC, Whalen DM. Synthesis of hexadecanolide. Ind Eng Chem Prod Res Dev 1975;14:232-239.
24. Morales G, Eyler GN, Cerna JR, Canizo AI. Use of cyclic di- and tri-peroxides as initiators of styrene polymerization at high temperature with a view to their use in industrial applications. Molecules 2000;5:549-550.
25. Terentev AO, Kutkin AV, Starikova ZA, Antipin MY, Ogibin YN, Nikishin GI. New preparation of 1, 2, 4, 5-tetraoxanes. Synthesis 2004;2356-2366.
26. Kim H-S, Nagai Y, Ono K, Begum K, Watayo Y, Hamada Y, Tsuchiya K, Masuyama A, Nojima M, McCullongh K. Synthesis and antimalarial activity of novel medium-sized 1, 2, 4, 5-tetraoxacycloalkanes. J Med Chem 2001;44:2357-2361.
27. Solaja BA, Terzic N, Pocsfalvi G, Genena L, Tinant B, Declerca JP, Kule DE, Milhous WK. Mixed steroidal 1, 2, 4, 5-tetraoxanes: Antimalarial and antimycobacterial activity. J Med Chem 2002;45:3331-3336.
28. Milas NA, Harris SA, Panagiotakos PC. Organic peroxides. VI. Cyclane peroxides. J Am Chem Soc 1939;61:2430.
29. Adam W, Asensio G, Curci R, Marco JA, Gonzaleznunnez ME, Melio R. One electron transfer chain decomposition of trifluoroacetone diperoxide: The first 1, 2, 4, 5-tetroxane with O-transfer capability. Tetrahedron Lett 1992;33:5833-5836.
30. Keul H. Ozonolysis of alkyliden- and benzylidenadamantanes. Chem Berg 1975;108:1198-1206.
31. Wojciechowski BJ, Pearson WH, Kuczkowski RL. Stereochemical effects in the ozonolysis of (E)- and (Z)-1-ethoxypropene. J Org Chem 1989;54:115-121.
32. Ito Y, Yokaya H, Umehara Y, Matsuura T. Formation of ketone diperoxides from ozonization of O-methyloximes. Bull Chem Soc Jpn 1980;53:2407-2408.
33. Jefford CW, Boukouvalas AJJ. Efficient preparation of 1, 2, 4, 5-tetroxanes from bis(trimethylsilyl) peroxide and carbonyl compounds. Synthesis 1988;391-393.
34. Opsenica D, Poesfalvi G, Juranic Z, Tinant B, Declerca JP, Kule DE, Milhous WK, Solaja BA. Cholic acid derivatives as 1, 2, 4, 5-tetraoxane carriers: Structure and antimalarial and antiproliferative activity. J Med Chem 2000;43:3274-3282.
35. Todorovic NM, Stefanovic M, Tinant B, Declercq J-P, Makler MT, Solaja BA. Steroidal geminal dihydroperoxides and 1, 2, 4, 5-tetraoxanes: Structure determination and their antimalarial activity. Steroid 1996;61:688-696.
36. 2/MTO/fluorous alcohol system. Tetrahedron Lett 2003;44:6309-6312.
37. Kim H-S, Tsuchiya K, Shibata Y, Wataya Y, Ushigoe Y, Masuyama A, Nojima A, McCullongh K. Synthetic methods for unsymmetrically-substituted 1, 2, 4, 5-tetroxanes and of 1, 2, 4, 5, 7-pentoxocanes. J Chem Soc Perkin Trans I 1999;1867-1870.
38. Ghorai P, Dussault PH. Broadly applicable synthesis of 1, 2, 4, 5-tetraoxanes. Org Lett 2009;11:213-216.
39. McCullough KJ, Morgan AR, Nonhebel DC, Pauson PL, White GJ. Ketone-derived peroxides. Part III. Decomposition of cyclic peroxide derived from dialkyl ketones. J Chem Res Synop 1980;2:36-38, M0601.
40. Story PR, Lee B, Bishop CE, Denson DD, Busch P. Macrocyclic synthesis. II. Cyclohexanone peroxides. J Org Chem 1970;35:3059-3062.
41. Sanderson JR, Zeiler AG, Witterdink RJ. Improved synthesis of dicyclohexylidene diperoxide. J Org Chem 1975;40:2239-2241.
42. 13C NMR analyses. J Heterocycl Chem 2001;38:463-466.
43. Dong Y, Matile H, Chollet J, Kaminsky R, Wood JK, Vennerstrom JL. Synthesis and antimalarial activity of 11 dispiro-1, 2, 4, 5-tetraoxane analogs of WR 148999. 7, 8, 15, 16-Tetraoxadispiro[5.2.5.2]hexadecanes substituted at the 1 and 10 positions with unsaturated and polar functional groups. J Med Chem 1999;42:1477-1480.
44. Ganeshpure PA, Adam WR. α-Hydroxy hydroperoxides (perhydrates) as oxygen transfer agents in organic synthesis. Synthesis 1996;179-188.
45. Kharasch MS, Sosnovsky G. Structure of peroxides from cyclohexanone and hydrogen peroxide. J Org Chem 1958;23:1322-1326.
46. McCullough KJ, Wood JK, Bhattacharjee AK, Dong Y, Kyle DE, Milous WK, Vennerstrom JL. Methyl-substituted dispiro-1, 2, 4, 5-tetraoxanes: correlations of structural studies with antimalarial activity. J Med Chem 2000;43:1246-1249.
47. Dong Y, Andersen SL, Ager AL, Jr., Fu H, Miller RE, Wesche DL, Kyle DE, Gerena L, Walters SM, Wood JK, Edwards G, Holme AD, McLean WG, Milhous WK. Synthesis and antimalarial activity of sixteen dispiro-1, 2, 4, 5-tetraoxanes: Alkyl-substituted 7, 8, 15, 16-tetraoxadispiro[5.2.5.2]hexadecanes. J Med Chem 2000;43:2753-2758.
48. Opsenica I, Opsenica D, Smith KS, Milhous WK, Šolaja BA. Chemical stability of the peroxide bond enables diversified synthesis of potent tetraoxane antimalarials. J Med Chem 2008;51:2261-2266.
49. Opsenica I, Terzic N, Opsenica D, Angelovski G, Lehnig M, Eilbracht P, Tinant B, Juranic Z, Smith KS, Yang YS, Diaz DS, Smith PL, Milhous WK, Dokovic D, Solaja BA. Tetraoxane antimalarials and their reaction with Fe(II). J Med Chem 2006;49:3790-3799.
50. Procopiou PA, Baugh SPD, Flack SS, Inglis GGA. An extremely powerful acylation reaction of alcohols with acid anhydrides catalyzed by trimethylsilyl trifluoromethanesulfonate. J Org Chem 1998;63:2342-2347.
51. Kim H-S, Shibata Y, Wataya Y, Tsuchiya K, Masuyama A, Nojima M. Synthesis and antimalarial activity of cyclic peroxides, 1, 2, 4, 5, 7-pentoxocanes and 1, 2, 4, 5-tetroxanes. J Med Chem 1999;42:2604-2609.
52. Kim H-S, Tsuchiya K, Shibata Y, Wataya Y, Ushigoe Y, Masuyama A, Nojima M, McCullough KJ. Synthetic methods for unsymmetrically-substituted 1, 2, 4, 5-tetroxanes and of 1, 2, 4, 5, 7-pentoxocanes. J Chem Soc Perkin Trans 1999;1:1867-1870.
53. O'Neill PM, Miller A, Bishop LPD, Hindley S, Maggs JL, Ward SA, Roberts SM, Scheinmann F, Stachulski AV, Posner GH, Park BK. Synthesis, antimalarial activity, biomimetic iron(II) chemistry and in vivo metabolism of novel, potent C-10-phenoxy derivatives of dihydroartemisinin. J Med Chem 2001;44:58-68.
54. Atheaya H, Khan SI, Mamgain R, Rawat DS. Synthesis, thermal stability, antimalarial activity of symmetrically and asymmetrically substituted tetraoxanes. Bioorg Med Chem Lett 2008;18:1446-1449.
55. Kumar N, Khan SI, Sharma M, Atheaya H, Rawat DS. Iodine-catalyzed one-pot synthesis and antimalarial activity evaluation of symmetrically and asymmetrically substituted 3, 6-diphenyl [1, 2, 4, 5]tetraoxanes. Bioorg Med Chem Lett 2009;19:1675.
56. Kumar N, Khan SI, Beena, Rajalakshmi G, Kumaradhas P. Rawat DS, Synthesis antimalarial activity and cytotoxicity of substituted 3, 6-diphenyl-[1, 2, 4, 5]tetraoxanes. Bioorg Med Chem 2009;17:5632.
57. Rawat DS, Kumar N, Sharma M. Symmetrically and asymmetrically substituted tetraoxane compounds, methods of preparation and uses thereof. Indian Patent Application No: 2103/DEL/2008.
58. Opsenica D, Kyle DE, Milous WK, Solaja BA. Antimalarial, antimycobacterial and antiproliferative activity of phenyl substituted mixed tetraoxanes. J Serb Chem Soc 2003;68:291-302.
59. Opsenica D, Angelovski G, Pocsfalvi G, Juranic Z, Zizak Z, Kyle D, Milhouse WK, Solaja BA. Antimalarial and antiproliferative evaluation of bis-steroidal tetraoxanes. Bioorg Med Chem 2003;11:2761-2768.
60. Opsenica IM, Smith KK, Gerena L, Gaica S, Šolaja BA. Ribofuranose as a carrier of tetraoxane and 4-aminoquinoline antimalarial pharmacophores. J Serb Chem Soc 2008;73:1021-1025.
61. Posner GH, Wang D, Cumming JN, Oh CH, French AN, Bodley AL, Shapiro TA. Further evidence supporting the importance of and the restrictions on a carbon-centered radical for high antimalarial activity of 1, 2, 4-trioxanes like artemisinin. J Med Chem 1995;38:2273-2275.
62. Butler AR, Gilbert BC, Hulme P, Irvine LR, Renton L, Whitwood AC. EPR evidence for the involvement of free radicals in the iron-catalyzed decomposition of qinghaosu (artemisinin) and some derivatives; antimalarial action of some polycyclic endoperoxides. Free Radical Res 1998;28:471-476.
63. O'Neill PM, Bishop LP, Searle NL, Maggs JL, Storr RC, Ward SA, Park BK, Mabbs F. Biomimetic Fe(II)-mediated degradation of arteflene (Ro-42-1611). The first EPR spin-trapping evidence for the previously postulated secondary carbon-centered cyclohexyl radical. J Org Chem 2000;65:1578-1582.
64. O'Neill PM, Searle NL, Maggs JL, Yaynes KJ, Ward SA, Storr RC, Park BK, Posner GH. A carbonyl oxide route to antimalarial Yingzhaosu A analogs: Synthesis and antimalarial activity. Tetrahedron Lett 1998;39:6065-6068.
65. Kamchonwongpaisan S, Paitayatat S, Thebtaranonth Y, Wilairat P, Yutharong Y. Mechanism-based development of new antimalarials: Synthesis of derivatives of artemisinin attached to iron chelators. J Med Chem 1995;38:2311-2316.
66. Meunier B. Hybrid molecules with a dual mode of action: Dream or reality? Acc Chem Res 2008;41:69-77.
67. Amewu R, Stachulski AV, Ward SA, Berry NG, Bray PG, Davies J, Labat G, Vivas L, O'Neill PM. Design and synthesis of orally active dispiro-1, 2, 4, 5-tetraoxanes; Synthetic antimalarials with superior activity to artemisinin. Org Biomol Chem 2006;4:4431-4436.
68. Opsenica I, Opsenica D, Lanteri CA, Anova L, Milhous WK, Smith KS, Solaja BA. Chemical stability of the peroxide bond enables diversified synthesis of potent tetraoxane antimalarials. J Med Chem 2008;51:2261-2266.
69. Vennerstrom JL, Arbe-Barnes S, Brun R, Chavman SA, Chiv FCK. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 2004;430:900-904.
70. Haynes RK. From artemisinin to new artemisinin antimalarials: Biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements. Curr Top Med Chem 2006;6:509-537.
71. Ellis GL, Amewu R, Sabbani S, Stocks PA, Shone A, Stanford D, Gibbons P, Davies J, Vivas L, Charnand S, Bongard E, Hall C, Rimmer K, Lozanom S, Jesus M, Gargallo D, Ward SA, O'Neill PM. Two-step synthesis of achiral dispiro-1, 2, 4, 5-tetraoxanes with outstanding antimalarial activity, low toxicity and high-stability profiles. J Med Chem 2008;51:2170-2177.
72. Peters W, Fleck SL, Robinson BL, Stewart LB, Jefford CW. The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials. Ann Trop Med Parasitol 2002;96:559.
73. Dechy-Cabaret O, Benoit-Vical F, Robert A, Meunier B. Preparation and antimalarial activities of "trioxaquines", new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. ChemBioChem 2000;1:281-283.
74. Opsenica I, Opsenica D, Lanteri CA, Anova L, Milhous WK, Smith KS, Solaja BA. New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton. J Med Chem 2008;51:6216-6219.
75. Zmitek K, Stavber S, Zupan M, Bonnet-Delpon D, Charnenu S, Grellier P, Iskara I. Synthesis and antimalarial activities of novel 3, 3, 6, 6-tetraalkyl-1, 2, 4, 5-tetraoxanes. Bioorg Med Chem 2006;14:7790-7795.
76. Dong YX, Chollet J, Matile H, Charman S, Chiu FCK, Charmabn WN, Scorneaux B, Urwyler H, Tomas JS, Scheurer C, Synder C, Dorn A, Wang XF, Karle JM, Tang VQ, Wittlin S, Brun R, Vennerstrom JL. Spiro and dispiro-1, 2, 4-trioxolanes as antimalarial peroxides: Charting a workable structure-activity relationship using simple prototypes. J Med Chem 2005;48:4953-4961.
77. Magueur G, Croussae B, Cherneau S, Grellier P, Begne JP, Bonnet-Delpon D. Fluoroartemisinin: Trifluoromethyl analogues of artemether and artesunate. J Med Chem 2004;47:2694-2699.
78. Ellis GL, Amewu R, Hall C, Rimmer K, Ward SA, O'Neill PM. An efficient route into synthetically challenging bridged achiral 1, 2, 4, 5-tetraoxanes with antimalarial activity. Bioorg Med Chem 2008;18:1720-1724.
79. Terent'ev AO, Borisov DA, Chernyshev VV, Nikishin GI. Facile and selective procedure for the synthesis of bridged 1, 2, 4, 5-tetraoxanes; Strong acids as cosolvents and catalysts for addition of hydrogen peroxide to α-diketones. J Org Chem 2009;74:3335-3340.
80. Eckstein-Ludwig U, Webb RJ, Van goethem IDI, East JM, Lee AG, Kimura O, O' Neill PM, Bray PG, Ward SA, Krishan S. Artemisinins target the SERCA of Plasmodium falciparum. Nature 2003;424:957-961.
81. Berman PA, Adams PA. Artemisinin enhances heme-catalyzed oxidation of lipid membranes. Free Radical Biol Chem 1997;22:1283-1288.
82. Tonmunphean S, Wijitkoboom A, Tantirungrotechai Y. Influence of stereoisomer of dispiro-1, 2, 4, 5-tetraoxanes on their binding mode with heme and on antimalarial activity: Molecular docking studies. Bioorg Med Chem 2004;12:2005-2012.
83. Liu H-H, Wu Y-K, Shen X. Alkylation of sulfur ligand in cysteinate-iron chelates by a 1, 2, 4, 5-tetraoxane. Chin J Chem 2003;21:875-877.
84. Jefford CW, Vicente MGU, Jacquier Y, Fararger F, Maveda J, Millasson-Schmidt P, Brunner G, Burger V. The deoxygenation and isomerization of artemisinin and artemether and their relevance to antimalarial action. Helv Chem Acta 1996;79:1475-1487.
85. Frejaville C, Karoui H, Tuccio B, Le moigne F, Culcasi M, Pieyri S, Lauricella R, Tordo D. 5-(Diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide: A new efficient phosphorylated nitrone for the in vitro and in vivo spin trapping of oxygen-centered radicals. J Med Chem 1995;38:258-265.
86. Posner GH, Cumming JN, Ploypradith P, Oh C-H. Evidence for Fe(IV):O in the molecular mechanism of action of the trioxane antimalarial artemisinin. J Am Chem Soc 1995;117:5885-5886.
87. Kapetanaki S, Varotsis C. Ferryl-oxo heme intermediate in the antimalarial mode of action of artemisinin. FEBS Lett 2000;474:238-241.
88. Kapetanaki S, Varotsis C. Fourier transform infrared investigation of non-Heme Fe(III) and Fe(II) decomposition of artemisinin and of a simplified trioxane alcohol. J Med Chem 2001;44:3150-3156.
89. Kumara N, Furukawa H, Dnyango AN, Izumi M, Nakajima S, Ito H, Hatano T, Kim H-S, Wataya Y, Baba N. Different behavior of artemisinin and tetraoxane in the oxidative degradation of phospholipid. Chem Phys Lipids 2009;160:114-120.
90. Dong Y, Creek D, Chollet J, Matile H, Charman SA, Wittin S, Wood JK, Vennerstrom JL. Comparative antimalarial activities of six pairs of 1, 2, 4, 5-tetraoxanes (peroxide dimers) and 1, 2, 4, 5, 7, 8-hexaoxonanes (peroxide trimers). Antimicrob Agents Chemother 2007;51:3033-3035.